Data / Form D filings / AcuraStem Inc
AcuraStem Inc: Form D filings
AcuraStem Inc, a biotechnology company in Pasadena, CA, filed 5 Form D notices with the SEC between 2018 and 2026. The latest, on June 22, 2026, reports an offering of $5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 150 North Orange Grove Blvd. Suite 220, Pasadena, CA, 91103
- Phone
- (213) 290-0635
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1745880
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Nov 30, 2022 | New notice | $3,110,332 | $3,110,332 | 1 | Nov 21, 2022 | sec.gov | |
| Nov 22, 2022 | New notice | $3,500,000 | $400,000 | $3,100,000 | 1 | Nov 11, 2022 | sec.gov |
| Jun 19, 2019 | Amendment | $2,000,000 | $380,000 | $1,620,000 | 1 | Jun 20, 2018 | sec.gov |
| Jul 12, 2018 | New notice | $3,000,000 | $50,000 | $2,950,000 | 1 | Jun 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samuel Alworth | Executive Officer, Director | |
| Paul August | Director | |
| Justin Ichida | Director | |
| Qing Liu-Michael | Director | |
| Marcel van der Brug | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AcuraStem Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.